Edwards Lifesciences to Present at the 31st Annual J.P. Morgan Healthcare Conference

IRVINE, CA -- (Marketwire) -- 01/02/13 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco, California on Monday, January 7, 2013.

Michael A. Mussallem, Edwards Lifesciences' chairman and chief executive officer, is scheduled to speak to conference attendees at 4:00 p.m. PST (7:00 p.m. EST). A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://ir.edwards.com. An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section and via the Edwards Lifesciences Investor Relations App for mobile devices.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation.